FindTrial
Sign In

Risk Factors for Cancer Therapy-Related Cardiovascular Toxicity in Breast Cancer Patients

Risk Factors for Cancer Therapy-Related Cardiovascular Toxicity in Breast Cancer Patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600117436
Enrollment
Unknown
Registered
2026-01-23
Start date
2025-12-16
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer therapy-related cardiovascular toxicity in breast cancer

Interventions

Cardiotoxicity Occurrence Group:None
Cardiotoxicity Non-occurrence Group:None

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 110 Years

Inclusion criteria

Inclusion criteria: 1. Pathologically confirmed breast cancer, with receipt of at least one type of anti-tumor therapy among radiotherapy, chemotherapy, targeted therapy, immunotherapy, and endocrine therapy; 2. Age >= 18 years old; 3. Complete 1-year follow-up data.

Exclusion criteria

Exclusion criteria: 1. Patients with pre-existing cardiovascular diseases where the association between cardiovascular events and tumor therapy cannot be distinguished; 2. Patients with incomplete follow-up data.

Design outcomes

Primary

MeasureTime frame
Cardiac Biomarker Panel;B-type Natriuretic Peptide;Cardiac Troponin;Left Ventricular Ejection Fraction;Electrocardiogram;—

Countries

China

Contacts

Public ContactWei Yun

Shanghai General Hospital

1156652632@qq.com+86 158 2194 6435

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026